NASDAQ Global Select • Healthcare • Biotechnology • US • USD
Puma Biotechnology, Inc. (PBYI) has a consensus analyst rating of Buy, based on 19 analysts covering the stock. Of those, 8 recommend buying, 7 recommend holding, and 4 recommend selling.
No price target data available.
Be the first to know when stocks drop below their intrinsic value.
